Q3 2019

Filed Nov 14, 2019 · 10-Q · 45 days after period end · 0001493152-19-017464

Q3 2019 · 10-Q

Revenue—

Net Income

-$5.23M

N/M vs Q3 2018

EPS Diluted

-$0.10

N/M vs Q3 2018

Operating Income-$5,257,000N/M

Operating Cash Flowderived-$4,851,000N/M

Same quarter

Metric	Q3 2019	Q3 2018	Q3 2017	Q3 2016
Revenue	—	—	—	$0.00
Net Income	-$5.23M	-$2.97M	-$6.91M	-$2.60M
EPS Diluted	-$0.10	-$0.07	-$0.22	-$0.10

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Insight Molecular Diagnostics Inc. · CIK 1642380 · Engraved from SEC EDGAR